Opinion|Videos|September 12, 2024
From Trial to Practice: Applying Study Results to Real-World AD Management
Medical experts examine the practical application of clinical study results to real-world atopic dermatitis management strategies.
Advertisement
Episodes in this series
Advertisement
Related to this article
Treatment success reached 56.7% and total lesions fell 71.8% with up to 52 weeks of oral denifanstat, with no adverse event-related discontinuations.
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Shows Real-World Effectiveness and Improved Quality of Life in Chronic Hand Eczema
2
EADV 2026 Day 3: Long-Term Psoriasis Data and Emerging Therapeutic Targets Take Focus
3
Obefazimod Data Across Phase 3 and Long-Term Studies to Be Presented at UEG Week 2026
4
EADV 2026 Day 2: Long-Term AD Data, GLP-1 Nail Findings, and Emerging Treatments Take Center Stage
5